InvestorsHub Logo
Followers 122
Posts 17458
Boards Moderated 0
Alias Born 01/06/2014

Re: None

Thursday, 06/20/2019 10:02:37 AM

Thursday, June 20, 2019 10:02:37 AM

Post# of 426317
My opinion for 2019 is either there will be dilution or a buyout. One of these two will happen, IMO.

I'm convinced that Amarin wants to sell, but only at the right price. Yes, I'm aware that the BOD can only recommend and shareholder get to decide.

Once sNDA is approved, the owner of Vascepa must go on a massive advertising blitz. Should cost a ton.

Could they partner in EU and use a chunk of that upfront payment for the above? Ehhh I guess, but unlikely, IMO.


95% certain they're set on selling (if the prices is right)

>99% certain label expansion occurs

90% TG > 135

90% no Adcom

2019:
50% buyout / massive partnership in USA
40% dilution (annoying but not the end of thr world)
5% EU partnership
5% none of the above






Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent AMRN News